These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35550847)

  • 1. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
    Zola Matuvanga T; Larivière Y; Lemey G; De Bie J; Milolo S; Meta R; Esanga E; Vermeiren PP; Thys S; Van Geertruyden JP; Van Damme P; Maketa V; Matangila J; Mitashi P; Muhindo-Mavoko H
    Vaccine; 2022 May; 40(25):3470-3480. PubMed ID: 35550847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Iris Scanning for Biometric Recognition of Healthy Adults Participating in an Ebola Vaccine Trial in the Democratic Republic of the Congo: Mixed Methods Study.
    Zola Matuvanga T; Johnson G; Larivière Y; Esanga Longomo E; Matangila J; Maketa V; Lapika B; Mitashi P; Mc Kenna P; De Bie J; Van Geertruyden JP; Van Damme P; Muhindo Mavoko H
    J Med Internet Res; 2021 Aug; 23(8):e28573. PubMed ID: 34378545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainable strategies for Ebola virus disease outbreak preparedness in Africa: a case study on lessons learnt in countries neighbouring the Democratic Republic of the Congo.
    Ryan CS; Belizaire MD; Nanyunja M; Olu OO; Ahmed YA; Latt A; Kol MT; Bamuleke B; Tusiime J; Nsabimbona N; Conteh I; Nyashanu S; Ramadan PO; Woldetsadik SF; Nkata JM; Ntwari JT; Nzeyimana SD; Ouedraogo L; Batona G; Ndahindwa V; Mgamb EA; Armah M; Wamala JF; Guyo AG; Freeman AYS; Chimbaru A; Komakech I; Kuku M; Firmino WM; Saguti GE; Msemwa F; O-Tipo S; Kalubula PC; Nsenga N; Talisuna AO
    Infect Dis Poverty; 2022 Dec; 11(1):118. PubMed ID: 36461100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo.
    Lemey G; Larivière Y; Zola TM; Maketa V; Matangila J; Mitashi P; Vermeiren P; Thys S; De Bie J; Muhindo HM; Ravinetto R; Van Damme P; Van Geertruyden JP
    BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34183329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
    Mbala-Kingebeni P; Villabona-Arenas CJ; Vidal N; Likofata J; Nsio-Mbeta J; Makiala-Mandanda S; Mukadi D; Mukadi P; Kumakamba C; Djokolo B; Ayouba A; Delaporte E; Peeters M; Muyembe Tamfum JJ; Ahuka-Mundeke S
    Clin Infect Dis; 2019 Jan; 68(2):330-333. PubMed ID: 29961823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ebola : an uncontrolled outbreak despite vaccines and new treatments].
    Vetter P; Kaiser L
    Rev Med Suisse; 2020 Apr; 16(690):739-743. PubMed ID: 32301308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus.
    Wolfe DN; Taylor MJ; Zarrabian AG
    Hum Vaccin Immunother; 2020 Nov; 16(11):2855-2860. PubMed ID: 32275465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons Learned from Reinforcing Epidemiologic Surveillance During the 2017 Ebola Outbreak in the Likati District, Democratic Republic of the Congo.
    Hemingway-Foday JJ; Ngoyi BF; Tunda C; Stolka KB; Grimes KEL; Lubula L; Mossoko M; Kebela BI; Brown LM; MacDonald PDM
    Health Secur; 2020 Jan; 18(S1):S81-S91. PubMed ID: 32004132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worries about Ebola outbreak grow, despite use of vaccine.
    Cohen J
    Science; 2018 Dec; 362(6420):1225. PubMed ID: 30545864
    [No Abstract]   [Full Text] [Related]  

  • 10. Ebola vaccines for mass immunisation in affected regions.
    Agnandji ST; Loembe MM
    Lancet Infect Dis; 2022 Jan; 22(1):8-10. PubMed ID: 34529960
    [No Abstract]   [Full Text] [Related]  

  • 11. Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
    Larivière Y; Zola T; Stoppie E; Maketa V; Matangila J; Mitashi P; De Bie J; Muhindo-Mavoko H; Van Geertruyden JP; Van Damme P
    BMJ Open; 2021 Sep; 11(9):e046835. PubMed ID: 34588237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study.
    Ebola Outbreak Epidemiology Team
    Lancet; 2018 Jul; 392(10143):213-221. PubMed ID: 30047375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethics of Conducting Clinical Research in an Outbreak Setting.
    Edwards KM; Kochhar S
    Annu Rev Virol; 2020 Sep; 7(1):475-494. PubMed ID: 32212920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opportunities and challenges of an Ebola modeling research coordination group.
    Rivers C; Pollett S; Viboud C
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008158. PubMed ID: 32673319
    [No Abstract]   [Full Text] [Related]  

  • 15. DR Congo: investigational research against Ebola virus.
    Green A
    Lancet; 2018 Jun; 391(10137):2308-2309. PubMed ID: 30047403
    [No Abstract]   [Full Text] [Related]  

  • 16. Ebola Virus Disease Outbreak - Democratic Republic of the Congo, August 2018-November 2019.
    Aruna A; Mbala P; Minikulu L; Mukadi D; Bulemfu D; Edidi F; Bulabula J; Tshapenda G; Nsio J; Kitenge R; Mbuyi G; Mwanzembe C; Kombe J; Lubula L; Shako JC; Mossoko M; Mulangu F; Mutombo A; Sana E; Tutu Y; Kabange L; Makengo J; Tshibinkufua F; Ahuka-Mundeke S; Muyembe JJ; Cdc ER;
    MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(50):1162-1165. PubMed ID: 31856146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola: global commitment for local engagement needed.
    Winters M; Nordenstedt H
    Eur J Public Health; 2019 Oct; 29(5):807. PubMed ID: 31557293
    [No Abstract]   [Full Text] [Related]  

  • 18. [Why does the Ebola virus epidemic continue to plague the Democratic Republic of the Congo?].
    Vanhecke C; Muwalawala J; Mbambu Mahamba MM; Girerd R; Gaüzère BA
    Rev Prat; 2021 Apr; 71(4):365-370. PubMed ID: 34160999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection, health seeking, or a laissez-passer: Participants' decision-making in an EVD vaccine trial in the eastern Democratic Republic of the Congo.
    James M; Kasereka JG; Kasiwa B; Kavunga-Membo H; Kambale K; Grais R; Muyembe-Tamfum JJ; Bausch DG; Watson-Jones D; Lees S
    Soc Sci Med; 2023 Apr; 323():115833. PubMed ID: 36934528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 1995 Kikwit Ebola outbreak--model of virus properties on system capacity and function: a lesson for future viral epidemics.
    Hall RC; Hall RC
    Am J Disaster Med; 2007; 2(5):270-6. PubMed ID: 18491842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.